...
首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry
【24h】

The liver-specific microRNA-122*, the complementary strand of microRNA-122, acts as a tumor suppressor by modulating the p53/mouse double minute 2 homolog circuitry

机译:肝脏特异性microRNA-122 *(microRNA-122的互补链)通过调节p53 /小鼠double minutes 2同源电路来充当肿瘤抑制因子

获取原文
获取原文并翻译 | 示例
           

摘要

The tumor suppressor p53 is a central regulator of signaling pathways that controls the cell cycle and maintains the integrity of the human genome. p53 level is regulated by mouse double minute 2 homolog (Mdm2), which marks p53 for proteasomal degradation. The p53-Mdm2 circuitry is subjected to complex regulation by a variety of mechanisms, including microRNAs (miRNAs). We found a novel effector of this regulatory circuit, namely, miR-122*, the passenger strand of the abundantly expressed liver-specific miR-122. Here, we demonstrate that miR-122* levels are reduced in human hepatocellular carcinoma (HCC). We found that miR-122* targets Mdm2, thus participating as an important player in the p53-Mdm2 circuitry. Moreover, we observed significant negative correlation between levels of miR-122* and Mdm2 in a large set of human HCC samples. In vivo tumorigenicity assays demonstrate that miR-122* is capable of inhibiting tumor growth, emphasizing the tumor-suppressor characteristics of this miRNA. Furthermore, we show that blocking miR-122 in murine livers with an antagomiR-122 (miRNA inhibitor) results in miR-122* accumulation, leading to Mdm2 repression followed by elevated p53 protein levels. Conclusion: miR-122*, the passenger strand of miR-122, regulates the activity of p53 by targeting Mdm2. Importantly, similarly to miR-122, miR-122* is significantly down-regulated in human HCC. We therefore propose that miR-122* is an important contributor to the tumor suppression activity previously attributed solely to miR-122. (Hepatology 2016;64:1623-1636)
机译:肿瘤抑制因子p53是控制细胞周期并维持人类基因组完整性的信号传导途径的中央调节剂。 p53水平受小鼠双分2同源物(Mdm2)调控,这标志着p53发生了蛋白酶体降解。 p53-Mdm2电路通过多种机制进行复杂的调节,包括microRNA(miRNA)。我们发现了这种调节回路的新型效应子,即miR-122 *,它是大量表达的肝脏特异性miR-122的过客链。在这里,我们证明了人类肝细胞癌(HCC)中miR-122 *水平降低。我们发现miR-122 *靶向Mdm2,因此作为p53-Mdm2电路的重要参与者。此外,我们在大量的人类HCC样本中观察到了miR-122 *和Mdm2水平之间的显着负相关。体内致瘤性分析表明,miR-122 *能够抑制肿瘤生长,强调了该miRNA的肿瘤抑制特征。此外,我们显示,用antagomiR-122(miRNA抑制剂)阻断鼠肝中的miR-122会导致miR-122 *积累,导致Mdm2抑制,然后升高p53蛋白水平。结论:miR-122的乘客链miR-122 *通过靶向Mdm2来调节p53的活性。重要的是,类似于miR-122,miR-122 *在人类HCC中明显下调。因此,我们提出miR-122 *是以前仅归因于miR-122的肿瘤抑制活性的重要贡献者。 (肝病学2016; 64:1623-1636)

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号